91 related articles for article (PubMed ID: 32903131)
1. Systematic review of the antiviral properties of TRIM56: a potential therapeutic intervention for COVID-19.
Heidary F; Gharebaghi R
Expert Rev Clin Immunol; 2020 Oct; 16(10):973-984. PubMed ID: 32903131
[TBL] [Abstract][Full Text] [Related]
2. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
3. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.
Liu B; Li NL; Wang J; Shi PY; Wang T; Miller MA; Li K
J Virol; 2014 Dec; 88(23):13821-35. PubMed ID: 25253338
[TBL] [Abstract][Full Text] [Related]
4. The Functions of TRIM56 in Antiviral Innate Immunity and Tumorigenesis.
Fu L; Zhou X; Jiao Q; Chen X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902478
[TBL] [Abstract][Full Text] [Related]
5. Impaired Antiviral Responses to Extracellular Double-Stranded RNA and Cytosolic DNA, but Not to Interferon-α Stimulation, in TRIM56-Deficient Cells.
Wang D; Wang R; Li K
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062293
[TBL] [Abstract][Full Text] [Related]
6. TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection.
Wang J; Liu B; Wang N; Lee YM; Liu C; Li K
J Virol; 2011 Apr; 85(8):3733-45. PubMed ID: 21289118
[TBL] [Abstract][Full Text] [Related]
7. The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not miRNA regulation, for antiviral function.
Yang D; Li NL; Wei D; Liu B; Guo F; Elbahesh H; Zhang Y; Zhou Z; Chen GY; Li K
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007537. PubMed ID: 31251739
[TBL] [Abstract][Full Text] [Related]
8. New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients.
Baskol G; Özel M; Saracoglu H; Ulger B; Kalin Unuvar G; Onuk S; Bayram A; Karayol Akin A; Muhtaroglu S; Sagiroglu P; Kilic E
Viral Immunol; 2022 Dec; 35(10):690-699. PubMed ID: 36450108
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA.
Tsuchida T; Zou J; Saitoh T; Kumar H; Abe T; Matsuura Y; Kawai T; Akira S
Immunity; 2010 Nov; 33(5):765-76. PubMed ID: 21074459
[TBL] [Abstract][Full Text] [Related]
10. TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling.
Chen Y; Zhao J; Li D; Hao J; He P; Wang H; Zhang M
Yonsei Med J; 2018 Jan; 59(1):43-50. PubMed ID: 29214775
[TBL] [Abstract][Full Text] [Related]
11. TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis.
Wang B; Wang Z; Li Y; Shang Z; Liu Z; Fan H; Zhan R; Xin T
Front Immunol; 2024; 15():1327898. PubMed ID: 38348047
[TBL] [Abstract][Full Text] [Related]
12. Expression of
Tavakoli R; Rahimi P; Hamidi-Fard M; Eybpoosh S; Doroud D; Ahmadi I; Anvari E; Aghasadeghi M; Fateh A
Future Virol; 2023 Jun; 18(9):563-574. PubMed ID: 38051999
[TBL] [Abstract][Full Text] [Related]
13. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
14. The Matrix Protein of Nipah Virus Targets the E3-Ubiquitin Ligase TRIM6 to Inhibit the IKKε Kinase-Mediated Type-I IFN Antiviral Response.
Bharaj P; Wang YE; Dawes BE; Yun TE; Park A; Yen B; Basler CF; Freiberg AN; Lee B; Rajsbaum R
PLoS Pathog; 2016 Sep; 12(9):e1005880. PubMed ID: 27622505
[TBL] [Abstract][Full Text] [Related]
15. Tripartite motif-containing proteins precisely and positively affect host antiviral immune response.
Wei Y; Chen S; Wang M; Cheng A
Scand J Immunol; 2018 Jun; 87(6):e12669. PubMed ID: 29706026
[TBL] [Abstract][Full Text] [Related]
16. TRIM proteins: another class of viral victims.
Munir M
Sci Signal; 2010 Apr; 3(118):jc2. PubMed ID: 20407122
[TBL] [Abstract][Full Text] [Related]
17. MiR-9 promotes multiple myeloma progression by regulating TRIM56/NF-κB pathway.
Huang G; Liu X; Zhao X; Zhao J; Hao J; Ren J; Chen Y
Cell Biol Int; 2019 Nov; 43(11):1223-1233. PubMed ID: 30637864
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the recognition and degradation of host TRIM proteins by Salmonella effector SopA.
Fiskin E; Bhogaraju S; Herhaus L; Kalayil S; Hahn M; Dikic I
Nat Commun; 2017 Jan; 8():14004. PubMed ID: 28084320
[TBL] [Abstract][Full Text] [Related]
20. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
